Influence
July 1, 2025

Shortening the Patient Health Questionnaire–9—When Brief Scales May Suffice

Kurt Kroenke, MD

Published in JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kurt Kroenke, MD

A new depression screening tool, the Quick PHQ-3 (QP-3), has been developed as a streamlined version of the widely used 9-item Patient Health Questionnaire (PHQ-9). The QP-3 includes just three items—interest, depressed mood and self-esteem—and demonstrated 98% sensitivity and 76% specificity in identifying moderate or greater depression symptoms.

The tool was evaluated using data from over 96,000 respondents across all 50 U.S. states. The study employed advanced psychometric techniques and was conducted in four waves to ensure reliability across a demographically diverse population. The QP-3’s performance was found to be comparable to longer instruments such as the 4-item PHQ-Dep-4.

Although the QP-3 has not yet been validated against structured psychiatric interviews, its utility is promising in scenarios where brief assessments are necessary. These include mobile health applications, large-scale health screenings or research settings where depression is a secondary outcome.

The full PHQ-9 remains the preferred tool when comprehensive evaluation is required. It captures the full range of diagnostic criteria for major depressive disorder, tracks residual symptoms, includes a critical item on suicidal ideation and supports treatment decisions based on established severity cutoffs.

Additionally, a “gated” approach—using a single-item screener followed by the remaining items only when necessary—has shown potential to cut response burden by nearly half without compromising accuracy.

The availability of brief validated screeners like the QP-3 enhances options for mental health assessment across diverse settings and populations.

Authors:

Kurt Kroenke1,2

Affiliations

1Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis

2Regenstrief Institute Inc, Indianapolis, Indiana

Partners

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher